[
  {
    "ts": null,
    "headline": "Molina Healthcare (MOH) PT Lowered to $124 by Goldman Sachs Following Q4 Earnings Miss",
    "summary": "Molina Healthcare Inc. (NYSE:MOH) is one of the most undervalued mid cap stocks to buy now. On February 12, Goldman Sachs lowered its price target on Molina Healthcare to $124 from $167 while keeping a Neutral rating. This adjustment was made following the company’s Q4 2025 earnings miss. The firm noted that the return profiles […]",
    "url": "https://finnhub.io/api/news?id=1d08c69687d7d447f5ce22ede366ae4827708ce92f50ba509fa52cfdde35209c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771050267,
      "headline": "Molina Healthcare (MOH) PT Lowered to $124 by Goldman Sachs Following Q4 Earnings Miss",
      "id": 139093674,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MOH",
      "source": "Yahoo",
      "summary": "Molina Healthcare Inc. (NYSE:MOH) is one of the most undervalued mid cap stocks to buy now. On February 12, Goldman Sachs lowered its price target on Molina Healthcare to $124 from $167 while keeping a Neutral rating. This adjustment was made following the company’s Q4 2025 earnings miss. The firm noted that the return profiles […]",
      "url": "https://finnhub.io/api/news?id=1d08c69687d7d447f5ce22ede366ae4827708ce92f50ba509fa52cfdde35209c"
    }
  }
]